395 related articles for article (PubMed ID: 19789069)
1. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.
Obrosova IG
Neurotherapeutics; 2009 Oct; 6(4):638-47. PubMed ID: 19789069
[TBL] [Abstract][Full Text] [Related]
2. Animal models of diabetic neuropathic pain.
Gao F; Zheng ZM
Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):100-6. PubMed ID: 24554509
[TBL] [Abstract][Full Text] [Related]
3. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced oxidative stress and pro-inflammatory markers differentiate the development of diabetic neuropathy variants in streptozotocin-induced diabetic rats.
Ismail CAN; Aziz CBA; Suppian R; Long I
J Diabetes Metab Disord; 2018 Dec; 17(2):129-136. PubMed ID: 30918846
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin.
Ma J; Yu H; Liu J; Chen Y; Wang Q; Xiang L
Eur J Pharmacol; 2015 Oct; 764():599-606. PubMed ID: 26054810
[TBL] [Abstract][Full Text] [Related]
6. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
Stevens MJ; Zhang W; Li F; Sima AA
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E497-505. PubMed ID: 15126237
[TBL] [Abstract][Full Text] [Related]
7. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
[TBL] [Abstract][Full Text] [Related]
8. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
Calcutt NA; Freshwater JD; Mizisin AP
Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
[TBL] [Abstract][Full Text] [Related]
9. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
[TBL] [Abstract][Full Text] [Related]
10. The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy.
Santos DFS; Donahue RR; Laird DE; Oliveira MCG; Taylor BK
Neuropharmacology; 2022 Mar; 205():108907. PubMed ID: 34856203
[TBL] [Abstract][Full Text] [Related]
11. The Different Dynamic Changes of Nerve Growth Factor in the Dorsal Horn and Dorsal Root Ganglion Leads to Hyperalgesia and Allodynia in Diabetic Neuropathic Pain.
Gao Z; Feng Y; Ju H
Pain Physician; 2017 May; 20(4):E551-E561. PubMed ID: 28535564
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model.
Sweitzer SM; Medicherla S; Almirez R; Dugar S; Chakravarty S; Shumilla JA; Yeomans DC; Protter AA
Pain; 2004 Jun; 109(3):409-419. PubMed ID: 15157702
[TBL] [Abstract][Full Text] [Related]
13. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
Kamiya H; Murakawa Y; Zhang W; Sima AA
Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
[TBL] [Abstract][Full Text] [Related]
14. BTD: A TRPC5 activator ameliorates mechanical allodynia in diabetic peripheral neuropathic rats by modulating TRPC5-CAMKII-ERK pathway.
Adhya P; Vaidya B; Sharma SS
Neurochem Int; 2023 Nov; 170():105609. PubMed ID: 37673218
[TBL] [Abstract][Full Text] [Related]
15. Minocycline reduces mechanical allodynia and depressive-like behaviour in type-1 diabetes mellitus in the rat.
Amorim D; Puga S; Bragança R; Braga A; Pertovaara A; Almeida A; Pinto-Ribeiro F
Behav Brain Res; 2017 Jun; 327():1-10. PubMed ID: 28286285
[TBL] [Abstract][Full Text] [Related]
16. Evoked hypoalgesia is accompanied by tonic pain and immune cell infiltration in the dorsal root ganglia at late stages of diabetic neuropathy in mice.
Agarwal N; Helmstädter J; Rojas DR; Bali KK; Gangadharan V; Kuner R
Mol Pain; 2018; 14():1744806918817975. PubMed ID: 30453826
[TBL] [Abstract][Full Text] [Related]
17. Ifenprodil Reduced Expression of Activated Microglia, BDNF and DREAM Proteins in the Spinal Cord Following Formalin Injection During the Early Stage of Painful Diabetic Neuropathy in Rats.
Ismail CAN; Suppian R; Ab Aziz CB; Long I
J Mol Neurosci; 2021 Feb; 71(2):379-393. PubMed ID: 32671697
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.
Obrosova IG; Ilnytska O; Lyzogubov VV; Pavlov IA; Mashtalir N; Nadler JL; Drel VR
Diabetes; 2007 Oct; 56(10):2598-608. PubMed ID: 17626889
[TBL] [Abstract][Full Text] [Related]
19. Potential mechanisms of neuropathic pain in diabetes.
Calcutt NA
Int Rev Neurobiol; 2002; 50():205-28. PubMed ID: 12198811
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.
Baumgärtner U; Magerl W; Klein T; Hopf HC; Treede RD
Pain; 2002 Mar; 96(1-2):141-51. PubMed ID: 11932070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
